Story thread · 2 reports / 2 sources
FDA Clears Novel Alzheimer's Blood Test
medpagetoday.com · 5h · first report
(MedPage Today) -- The FDA cleared the PrecivityAD2 blood test to help diagnose Alzheimer's disease as part of a standard clinical workup, C2N Diagnostics announced Thursday. The test, which measures plasma amyloid beta and tau peptide ratios...
The coverage
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.